Dr. Samuel So is the Lui Hac Minh Professor and Professor of Surgery. He is also the founder of the multidisciplinary liver cancer program at the Stanford Cancer Center, and the founder and executive director of the Asian Liver Center at Stanford University School of Medicine. Dr. So is a native of Hong Kong and received his surgical training at the University of Hong Kong and the University of Minnesota where he also completed his fellowship in multi-organ transplantation.
Dr. Sabine Heitzeneder’s research bridges the rational discovery of promising, tumor-restricted target antigens expressed on childhood cancer, that are absent from normal, vital tissue in the body and the robust pre-clinical development of adoptive cellular immunotherapies tailored to these antigens, that are suitable for phase I clinical testing in patients.
Dr. Ryann Fame, PhD, joined the faculty at Stanford University in 2022. Following her undergraduate degree in Biology and Chemistry at the College of William & Mary, Dr. Fame completed a PhD in Molecular and Cellular Biology at Harvard University. She conducted postdoctoral fellowships at The Whitehead Institute for Biomedical Research at MIT and at Boston Children’s Hospital Pathology Department. As a stem cell and developmental molecular biologist, Dr.
Dr. Ruth Huttenhain's group deciphers how G protein-coupled receptors decode extracellular cues into dynamic and context-specific cellular signaling networks to elicit diverse physiologic responses. They exploit quantitative proteomics to capture the spatiotemporal organization of signaling networks combined with functional genomics to study their impact on physiology.
